Status:
NOT_YET_RECRUITING
Effect of Multitarget tDCS for Neuropathic Pain
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborating Sponsors:
Beijing Tiantan Hospital
Second Affiliated Hospital of Tsinghua University
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study aims to conduct a randomized controlled trial to evaluate the effect of multitarget transcranial direct current stimulation (tDCS) on pain, depression, anxiety, quality of life and sleep, i...
Detailed Description
The present multicenter, randomized, double-blind, sham-controlled, parallel-group trial aims to evaluate the effect of multitarget transcranial direct current stimulation (tDCS) in patients with neur...
Eligibility Criteria
Inclusion
- Female or males aged between 18 and 75 years.
- Pain fulfilling the criteria for probable or definite neuropathic pain and scoring ≥4/10 at Douleur Neuropathique 4 Questions.
- Pain duration of at least 3 months and average pain intensity scoring ≥4/10 at Numeric Rating Scale.
- Stable pharmacological treatment for at least 4 weeks prior to the study and throughout the trial.
- Informed consent obtained.
Exclusion
- Pregnancy or lactation.
- Active central nervous system diseases including but not limited to brain tumour, intracranial hypertension, past or current epilepsy.
- Unable to complete the questionnaire due to language abilities or reduced cognitive functioning.
- Alcohol or substance abuse.
- Common contraindications for transcranial direct current stimulation including but not limited to skull defect, implanted device or metal in the brain, severe cardiopulmonary, renal or hepatic diseases.
- Unwilling to comply with the treatment or follow-up assessments.
- Participating in another clinical trial within 3 months prior to enrollment of this clinical trial.
- Any patient deemed unsuitable for enrollment by the investigators.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06510725
Start Date
August 1 2024
End Date
January 31 2026
Last Update
July 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.